Jonathan Wu

Jonathan Wu is a seasoned professional in corporate business development and strategy within the biotechnology and pharmaceutical sectors. Currently serving as Senior Director, Corporate Business Development, Transactions and M&A at Eli Lilly and Company since November 2025, Jonathan previously held senior roles at CARGO Therapeutics and CytomX Therapeutics, focusing on business development strategies, partnerships, and pipeline management. Prior experiences include leading product planning and marketing initiatives at Catalyst Biosciences, BeiGene, and Amgen, where Jonathan contributed to significant product launches in hematology/oncology. A foundation in management and strategy consulting was established at BioMedical Insights and Xelay Acumen, coupled with academic experience as a Teaching Assistant and Research Associate at UCLA. Jonathan holds a Bachelor's Degree in Cell Biology, Molecular Biology, and Genetics from Boston University.